Transcription factor AP-2beta inhibits expression and secretion of leptin, an insulin-sensitizing hormone, in 3T3-L1 adipocytes. (Q42830507)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Transcription factor AP-2beta inhibits expression and secretion of leptin, an insulin-sensitizing hormone, in 3T3-L1 adipocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

T Fuke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

T Yoshizaki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

M Kondo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

T Obata

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

S Ugi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Y Nishio

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

S Maeda

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

A Kashiwagi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

H Maegawa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

English

0 references

publication date

12 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

670-678

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20065963%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ijo.2009.295

16 January 2020

exact match

0 references

cites work

Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Intronic polymorphisms within TFAP2B regulate transcriptional activity and affect adipocytokine gene expression in differentiated adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

The transcription factor AP-2beta causes cell enlargement and insulin resistance in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Transcription factor activating enhancer-binding protein-2beta. A negative regulator of adiponectin gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Transcription factor activating protein-2beta: a positive regulator of monocyte chemoattractant protein-1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

The transcription factor TFAP2B is associated with insulin resistance and adiposity in healthy adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Adipocytokines and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Adipokines and the peripheral and neural control of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Weight-reducing effects of the plasma protein encoded by the obese gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Leptin and the regulation of body weight in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Correction of obesity and diabetes in genetically obese mice by leptin gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Congenital leptin deficiency is associated with severe early-onset obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Leptin-replacement therapy for lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in l6 myocytes and Fao hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Membrane-targeted phosphatidylinositol 3-kinase mimics insulin actions and induces a state of cellular insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Protein phosphatase-2C alpha as a positive regulator of insulin sensitivity through direct activation of phosphatidylinositol 3-kinase in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Regulation of ATP-sensitive potassium channel subunit Kir6.2 expression in rat intestinal insulin-producing progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Occupancy and function of the -150 sterol regulatory element and -65 E-box in nutritional regulation of the fatty acid synthase gene in living animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Molecular cloning and characterization of AP-2 epsilon, a fifth member of the AP-2 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Functional antagonism between CCAAT/Enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Skeletal muscle AMP-activated protein kinase phosphorylation parallels metabolic phenotype in leptin transgenic mice under dietary modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Rapid transformation of white adipocytes into fat-oxidizing machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Functions of AMP-activated protein kinase in adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Partial leptin deficiency and human adiposity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Relatively low plasma leptin concentrations precede weight gain in Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

Long-term leptin-replacement therapy for lipoatrophic diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

7 January 2021

Regulation of leptin promoter function by Sp1, C/EBP, and a novel factor

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

7 January 2021

Central melanocortin signaling restores skeletal muscle AMP-activated protein kinase phosphorylation in mice fed a high-fat diet

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

7 January 2021

Novel form of lipolysis induced by leptin

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

7 January 2021

Role of energy charge and AMP-activated protein kinase in adipocytes in the control of body fat stores

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.295

7 January 2021